Tharimmune Stock Gains 30%, on $540M Capital Raise to Build Canton Coin Treasury Strategy
Tharimmune Stock Gains 30%, on $540M Capital Raise to Build Canton Coin Treasury Strategy
2025-11-03
The nanocap biotech firm is pivoting into digital assets with a $540 million raise to build a canton coin–based treasury, backed by DRW and Liberty City Ventures.
Gönderiyi Paylaş
Ücretsiz kaydolun ve kripto yolculuğunuza başlayın.